Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Curent Deferred Tax Liability (2020 - 2026)

Evotec SE's (EVO) quarterly Curent Deferred Tax Liability came in at $8.2 million in Q2 2026, down 74.06% year-over-year from $31.7 million in Q2 2025, and down 8.97% quarter-over-quarter from $9.0 million in Q1 2026.

Analysis

Evotec SE (EVO) Curent Deferred Tax Liability (2020 - 2026) Analysis & Trends

Evotec SE has disclosed Curent Deferred Tax Liability across 6 years of filings, most recently posting $8.2 million for Q2 2026.

  • In Q2 2026, Curent Deferred Tax Liability fell 74.06% year-over-year to $8.2 million; the TTM figure through Jun 2026 stood at $8.2 million (down 74.06% YoY), while the FY2025 annual figure was $9.4 million, down 71.48% from the prior year.
  • Curent Deferred Tax Liability came in at $8.2 million for Q2 2026 at Evotec SE, down from $9.0 million in the prior quarter.
  • In the past five years, Curent Deferred Tax Liability ranged from a high of $32.7 million in Q4 2024 to a low of $517397.7 in Q1 2022.
  • Average Curent Deferred Tax Liability over 4 years is $16.6 million, with a median of $10.2 million recorded in 2025.
  • Year-over-year, Curent Deferred Tax Liability sank 70.23% in 2025 and plunged 74.06% in 2026.
  • Over 4 years, Curent Deferred Tax Liability stood at $517397.7 in 2022, then soared by 6211.02% to $32.7 million in 2024, then slumped by 70.23% to $9.7 million in 2025, then decreased by 15.42% to $8.2 million in 2026.
  • Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $8.2 million in Q2 2026, $9.0 million in Q1 2026, and $9.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax Liability (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn -
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -
6 Evotec SE 642.83 Mn 216.96 Mn - 8.22 Mn
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn -
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.22 Mn
Mar 31, 2026 9.03 Mn
Dec 31, 2025 9.72 Mn
Sep 30, 2025 10.67 Mn
Jun 30, 2025 31.70 Mn
Mar 31, 2025 30.66 Mn
Dec 31, 2024 32.65 Mn
Mar 31, 2022 517,397.69
Dec 31, 2021 1.14 Mn
Sep 30, 2021 1.81 Mn
Dec 31, 2020 4.40 Mn